2000
DOI: 10.1016/s0041-1345(00)01497-4
|View full text |Cite
|
Sign up to set email alerts
|

Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Steroid‐resistant rejection is also a risk‐factor for HCMV disease [15,16]. The risk of HCMV disease associated with anti‐thymocyte globulin and muromonab‐CD3 (OKT3) is higher when these agents are given as treatment of rejection than when they are used for induction therapy [17].…”
Section: Hcmv Infection and Diseasementioning
confidence: 99%
“…Steroid‐resistant rejection is also a risk‐factor for HCMV disease [15,16]. The risk of HCMV disease associated with anti‐thymocyte globulin and muromonab‐CD3 (OKT3) is higher when these agents are given as treatment of rejection than when they are used for induction therapy [17].…”
Section: Hcmv Infection and Diseasementioning
confidence: 99%